Rashmi Kshirsagar

Papers

Total Citations

H-Index

About

Rashmi Kshirsagar is a leading figure in bioprocess development, with a primary focus on accelerating the timeline for bringing monoclonal antibody (mAb) therapeutics from discovery to the clinic. Her key research areas include high-throughput cell culture technologies, process intensification, and the strategic design of upstream manufacturing platforms. Kshirsagar’s major contribution lies in demonstrating how advanced, high-throughput systems can drastically compress development schedules without compromising product quality. Her seminal 2015 case study, which has garnered significant attention in the field, provides a practical blueprint for reducing the time required to produce material for early-phase clinical trials—a critical bottleneck in the pharmaceutical industry. This work has been instrumental in helping biotech and pharmaceutical companies navigate the pressures of an increasingly competitive pipeline. By systematically integrating automation and miniaturized bioreactor systems, Kshirsagar has enabled faster decision-making and more efficient resource allocation. Her research continues to shape best practices for rapid process development, making her a pivotal voice in the ongoing effort to deliver novel therapeutics to patients more quickly and reliably.